Inverness Medical Innovations is committed to producing only the highest quality products at our facilities round the world, utilizing the most modern manufacturing practices and systems.  We are proud of our state-of-the-art technology, ongoing improvement programs and production teams, working within and across departments, combining to maintain the highest standards at each step of the manufacturing process. This ensures quality and helps our innovative products reach the market quickly.

Many of the reagents used in our products are manufactured using monoclonal antibodies produced in-house, together with other chemical reagents. These active components are deposited onto special membranes. The product performance is carefully managed to ensure exacting specifications are met. The active components from our technical production area are encased using a variety of unique and highly automated machines. The components are then packed on automated packing lines, producing a vast range of pack variants.

Our primary manufacturing facilities for our diagnostic products are in Hangzhou and Shanghai, China; Matsudo, Japan and San Diego, California, and we also manufacture these products at several sites in the US and the UK, as well as in Israel, Australia and South Africa. All of our important manufacturing facilities are ISO certified and registered with the United States Food and Drug Administration.

We also have a manufacturing operation in Irvington, New Jersey which produces substantially all of our softgel requirements. This facility manufactures to GMP standards applicable to drug makers and is registered with both the United States Drug Enforcement Agency and the FDA. We also have a packaging and distribution center for the consumer business in North America located in Freehold.